TB-500
Also known as: Thymosin Beta-4, Tβ4
TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4, which plays a crucial role in tissue repair and regeneration. It promotes the migration of endothelial and keratinocyte cells to sites of injury, reduces inflammation, and inhibits the formation of adhesions in muscles and tendons. Popular among athletes for recovery from injuries. However, human clinical trials remain limited, and it is not FDA-approved.
Synthetic version of thymosin beta-4 that promotes cell migration, reduces inflammation, and accelerates wound healing
| Parameter | Detail |
|---|---|
| Administration | Subcutaneous injection |
| Typical Dose | 2-5mg twice weekly |
| Frequency | Twice weekly |
Common Side Effects
Serious Side Effects
- Pregnancy
- Active cancer
- Children
Evidence Quality
Clinical Trial Phase
Preclinical / Not submitted
| Peptide | Monthly Cost | FDA Status |
|---|---|---|
| TB-500 | $40 - $80/mo | Not submitted |
| BPC-157 | $30 - $70/mo | Not submitted |
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy or medication. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary.